These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 10216166

  • 1. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration.
    Serrano J, Palmeira CM, Kuehl DW, Wallace KB.
    Biochim Biophys Acta; 1999 Apr 21; 1411(1):201-5. PubMed ID: 10216166
    [Abstract] [Full Text] [Related]

  • 2. Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin.
    Palmeira CM, Serrano J, Kuehl DW, Wallace KB.
    Biochim Biophys Acta; 1997 Aug 22; 1321(2):101-6. PubMed ID: 9332499
    [Abstract] [Full Text] [Related]

  • 3. Doxorubicin-induced persistent oxidative stress to cardiac myocytes.
    Zhou S, Palmeira CM, Wallace KB.
    Toxicol Lett; 2001 May 19; 121(3):151-7. PubMed ID: 11369469
    [Abstract] [Full Text] [Related]

  • 4. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
    Zhou S, Starkov A, Froberg MK, Leino RL, Wallace KB.
    Cancer Res; 2001 Jan 15; 61(2):771-7. PubMed ID: 11212281
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stilbene estrogen produces higher levels of mitochondrial DNA adducts than nuclear DNA adducts in the target organ of cancer (liver) of male Sprague Dawley rats.
    Thomas RD, Roy D.
    Oncol Rep; 2001 Jan 15; 8(5):1035-8. PubMed ID: 11496312
    [Abstract] [Full Text] [Related]

  • 7. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs.
    Balansky R, Izzotti A, Scatolini L, D'Agostini F, De Flora S.
    Cancer Res; 1996 Apr 01; 56(7):1642-7. PubMed ID: 8603414
    [Abstract] [Full Text] [Related]

  • 8. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.
    Carvalho RA, Sousa RP, Cadete VJ, Lopaschuk GD, Palmeira CM, Bjork JA, Wallace KB.
    Toxicology; 2010 Apr 11; 270(2-3):92-8. PubMed ID: 20132857
    [Abstract] [Full Text] [Related]

  • 9. Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA.
    Olivero OA, Chang PK, Lopez-Larraza DM, Semino-Mora MC, Poirier MC.
    Mutat Res; 1997 Jun 13; 391(1-2):79-86. PubMed ID: 9219551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy.
    Lebrecht D, Setzer B, Ketelsen UP, Haberstroh J, Walker UA.
    Circulation; 2003 Nov 11; 108(19):2423-9. PubMed ID: 14568902
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.
    Yang Z, Schumaker LM, Egorin MJ, Zuhowski EG, Guo Z, Cullen KJ.
    Clin Cancer Res; 2006 Oct 01; 12(19):5817-25. PubMed ID: 17020989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics.
    Marechal X, Montaigne D, Marciniak C, Marchetti P, Hassoun SM, Beauvillain JC, Lancel S, Neviere R.
    Clin Sci (Lond); 2011 Nov 01; 121(9):405-13. PubMed ID: 21605084
    [Abstract] [Full Text] [Related]

  • 18. Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention.
    De Flora S, Balansky R, Scatolini L, Di Marco C, Gasparini L, Orlando M, Izzotti A.
    IARC Sci Publ; 1996 Nov 01; (139):291-301. PubMed ID: 8923039
    [Abstract] [Full Text] [Related]

  • 19. Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
    Lebrecht D, Geist A, Ketelsen UP, Haberstroh J, Setzer B, Walker UA.
    Br J Pharmacol; 2007 Jul 01; 151(6):771-8. PubMed ID: 17519947
    [Abstract] [Full Text] [Related]

  • 20. The 6-maleimidocaproyl hydrazone derivative of doxorubicin (DOXO-EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage.
    Lebrecht D, Geist A, Ketelsen UP, Haberstroh J, Setzer B, Kratz F, Walker UA.
    Int J Cancer; 2007 Feb 15; 120(4):927-34. PubMed ID: 17131338
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.